With the advancement of molecular techniques, the histologic diagnosis of AT/RT has been increasingly supported by methods such as next-generation sequencing, deletion/duplication analyses, and tumor microarray testing to detect and confirm SMARCB1 or SMARCA4 alterations. The gene discussed is SMARCB1; the disease is ataxia telangiectasia.